Filing Flows › American Well (AMWL) › Guidance & outlook
American Well (AMWL) guidance and outlook
American Well (AMWL) raised its guidance on Nov 3, 2026: Revenue $1.3M–$1.4M for Q4 2026; Revenue $48.0M–$50.0M for Q4 2026; EBITDA $0–$1.0M for Q4 2026. American Well's 10-Q filed Nov 3, 2026 makes 13 forward-looking statements.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | Q4 2026 | $1.3M–$1.4M | new |
| Revenue | Q4 2026 | $48.0M–$50.0M | new |
| EBITDA | Q4 2026 | $0–$1.0M | new |
From the earnings release filed Nov 3, 2026 (8-K on EDGAR).
Forward-looking statements, 10-Q filed Nov 3, 2026
- the impact of the seasonal viruses on our business or on our ability to forecast our business’s financial outlook;
- We expect that our future revenues will be driven by the growing adoption of digital and hybrid care and our ability to maintain and grow market share within that market.
- We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook.
- In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measure as a tool for comparison.
- In evaluating adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments in this presentation.
- Our presentation of adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items.
- While we currently expect increased investments to further enhance our offering, we also expect increased efficiencies and economies of scale.
- Our quarterly cost of revenues as a percentage of revenues is expected to fluctuate from period to period depending on the interplay of these aforementioned factors.
- We will continue to invest appropriately in sales expenses as we look to grow with new prospects and expand the business of our existing clients.
- We will continue to elevate the skills and impact of our sales personnel and related account management teams as we look to provide a differentiated and enhanced client experience to our growing client base as well as identifying new strategic market opportunities.
- We expect sales and marketing expense to remain consistent in future periods.
- We expect our general and administrative expenses to remain relatively flat in future periods.
American Well's latest quarter
American Well, Q3 2026: revenue $49.0M (-13% year over year), operating margin -23.8%, net loss $11.0M, operating cash flow −$11.7M. The chart follows the revenue to costs, profit and cash.
Questions
Did American Well raise or lower its guidance?
American Well (AMWL) raised its guidance on Nov 3, 2026: Revenue $1.3M–$1.4M for Q4 2026; Revenue $48.0M–$50.0M for Q4 2026; EBITDA $0–$1.0M for Q4 2026.
What does American Well expect?
the impact of the seasonal viruses on our business or on our ability to forecast our business’s financial outlook; We expect that our future revenues will be driven by the growing adoption of digital and hybrid care and our ability to maintain and grow market share within that market. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measures, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations or outlook.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.